GlassScriptPhysician profile
Jonathan F Busbee
NPI 1346212792
$2,965.98
in general payments reported to CMS, 2019-2025
21 companies · $15.04 in 2025
The $15.04 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,178 · 2020: $787 · 2021: $620 · 2022: $56.13 · 2023: $191 · 2024: $119 · 2025: $15.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $269 · Debt Forgiveness: $56.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $268.90 |
| Debt Forgiveness | $56.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $898.50 | 2019-2023 | |
| Novo Nordisk INC | $547.15 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $307.07 | 2019-2024 | Jardiance |
| Janssen Pharmaceuticals, INC | $285.21 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $156.01 | 2019-2021 | |
| Pfizer INC. | $149.78 | 2019 | |
| Baxter Healthcare | $112.26 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $103.85 | 2019-2020 | |
| Lilly USA, LLC | $100.94 | 2019-2020 | |
| Welch Allyn | $56.13 | 2021 | |
| Sun Pharmaceutical Industries INC. | $47.46 | 2020 | |
| Eisai INC. | $40.59 | 2020 | |
| Allergan, INC. | $34.54 | 2019 | |
| Sumitomo Pharma America, INC. | $20.61 | 2023 | Gemtesa |
| E.R. Squibb & Sons, L.L.C. | $19.13 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $16.09 | 2020 | |
| Shire North American Group INC | $15.52 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $15.04 | 2025 | Abilify Maintena |
| Valeritas, INC. | $13.53 | 2019 | |
| Biogen, INC. | $13.50 | 2020 | |
| Grifols USA, LLC | $13.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Busbee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.